Ahsitwt: The present study was conducted to assess in rats the comparative effects of a number of chelating agents on the urinary excretion and tissue distribution of Al. Adult male Spraguc-Dawley rats received a single intraperitoneal dose of aluminium (Al) nitrate nonahydrdte (0.24 mmol/kg). Ten min. after A1 injection, 1.2-dimethyl-3-hydroxypirid-4-one, 2,3-dihydroxybenzoic acid, picolinic acid, methylmalonic acid, ethylenediamine-di(o-hydroxyphenylacetic) acid. l-benzyl-2-methyl-3-hydroxypyrid-4-one. I-@-methylbenzyI)-2-methyl-3-hydroxypyrid-4-one, I-@-methoxy-benzyl)-2-methyl-3-hydroxypyrid-4-one, I-@-chlorobenzyl)-2-methyl-3-hydroxypyrid-4-one~ I-benzyl-2-ethyl-3-hydroxypyrid-4-one, I-@-methylbenzyl)-2-ethyl-3-hydroxypyrid-4-one, l-[3-hydroxy-2-methyI-4-oxopyridyl]-2-ethanesulfonic acid and I-benzyl-(4-carboxylic acid)-3-hydroxy-2-methyl-4-oxopyridine were given by gavage at I .79 mniol/kg. A control group received similar volumes of distilled water. An additional group of rats received a subcutaneous injection of desferrioxamine at 1.79 mniol/ kg. Urine samples were collected daily for three consecutive days and the animals were killed after this period. Samples of brain, bone, liver. kidney and spleen were collected. Although desferrioxamine, 1,2-dimethyl-3-hydroxypirid-4-one. I -@-methylbenzyl)-2-methyl-3-hydroxypyrid-4-one, I-@-methoxybenzyl)-2-niethyl-3-hydroxypyrid-4-one. I-@-methylbenryl)-2-ethyl-3-hydroxypyrid-4-one, I-[3-hydroxy-2-niethyl-4-oxopyridyl]-2-ethanesulfonic acid and I-benzyl-(4-carboxylic acid)-3-hydroxy-2-methyl-4-oxopyridine significantly enhanced the total excretion of A1 into urine, only treatment with 1 -@-chlorobenzyl)-2-methyl-3-hydroxypyrid-4-one and l-benzyl-2-elhyl-3-hydroxypyrid-4-one significantly reduced Al concentrations in all analyzed tissues. No beneficial effects of the remaining chelators on A1 mobilization were observed. Further studies on the effects of some 3-hydoxrypyrid-4-ones on A1 removal can be of interest for the treatment of A1 accumulation and toxicity.